Atherosclerosis
Volume 183, Issue 1 , Pages 85-93, November 2005

Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-β from its activation

  • Yu-ichiro Sakamoto

      Affiliations

    • Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 96 373 5072; fax: +81 96 364 6940.
  • ,
  • Akira Miyazaki

      Affiliations

    • Department of Biochemistry, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan
  • ,
  • Harumi Tamagawa

      Affiliations

    • Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan
  • ,
  • Guo-Ping Wang

      Affiliations

    • Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan
  • ,
  • Seikoh Horiuchi

      Affiliations

    • Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan

Received 5 August 2004; received in revised form 25 February 2005; accepted 25 February 2005. published online 23 May 2005.

Abstract 

Oxidized LDL (Ox-LDL) plays atherogenic roles, whereas thrombospondin-1 (TSP-1) is thought to be anti-atherogenic through activation of TGF-β that contributes to plaque stabilization. Ox-LDL was prepared by incubating of human LDL with CuSO4. Effect of Ox-LDL on TSP-1-induced TGF-β activation was examined in the present study. Incubation of Ox-LDL with mouse peritoneal macrophages for 3 days resulted in reduction in amounts of active TGF-β in the culture medium by 70–78% when compared with that of parallel incubation without Ox-LDL. TSP-1 could enhance conversion of latent TGF-β1 into active TGF-β1 in a cell-free system. This TSP-1-mediated latent TGF-β1 activation was inhibited by 30% by Ox-LDL, suggesting the possible interaction of Ox-LDL with TSP-1. Incubation of TSP-1 with [125I]Ox-LDL or [125I]LDL, followed by immunoprecipitation with an anti-TSP-1 antibody demonstrated that a significant amount of [125I]Ox-LDL was co-precipitated with TSP-1 while precipitation of [125I]LDL was negligible. Furthermore, upon TSP-1-conjugated Sepharose 4B affinity chromatography, both [125I]Ox-LDL and [125I]latent TGF-β1 bound to the affinity gel were eluted by unlabeled Ox-LDL. These findings indicate that Ox-LDL interacts with TSP-1 and suppresses subsequent TSP-1-dependent TGF-β activation, revealing a novel atherogenic function of Ox-LDL.

Keywords: Oxidized low-density lipoprotein, Thrombospondin-1, Transforming growth factor-β, Atherosclerosis, Inflammation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(05)00200-5

doi:10.1016/j.atherosclerosis.2005.02.032

Atherosclerosis
Volume 183, Issue 1 , Pages 85-93, November 2005